Adductor Canal Block in Outpatient Clinic for Pain Control After Knee Arthroplasty

NCT ID: NCT04883034

Last Updated: 2021-05-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-01

Study Completion Date

2021-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Single-shot Adductor Canal Block in the outpatient clinic is safe, significantly decreased pain and analgesic consumption and may enhance the rehabilitation program

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The ACB in the outpatient clinic is safe and can minimize postoperative pain. The primary goal of this research was to see how ACB affected the Visual Analog Score (VAS) pain score during the rehabilitation as opposed to controls. The secondary goal was to determine how much analgesic (etoricoxibe) was consumed on a daily basis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Pain Total Knee Arthroplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

pain management post total knee arthroplasty with analgetic oral

Patients in control group were given analgesic (etoricoxibe) on a daily basis, with the option to increase the dose if pain persisted, up to a maximum of 120 mg per day.

Group Type PLACEBO_COMPARATOR

Analgesics, etoricoxibe

Intervention Type DRUG

anaelgetic oral intake

pain management post total knee arthroplasty with adductor canal block

On postoperative day 14 (POD 14), the ACB was performed for ACB group

Group Type ACTIVE_COMPARATOR

adductor canal block in outpatient clinic

Intervention Type PROCEDURE

perform adductor canal block in outpatient clinic for patient post total knee arthroplasty

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

adductor canal block in outpatient clinic

perform adductor canal block in outpatient clinic for patient post total knee arthroplasty

Intervention Type PROCEDURE

Analgesics, etoricoxibe

anaelgetic oral intake

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

etoricoxibe

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Indonesian or Javanese-speaking adults
* After perfomed total knee replacement
* American Society of Anesthesiologists physical status I-III
* body mass index (BMI) of 18-40 kg/m2

Exclusion Criteria

* Declined to complete the study
* Unable to cooperate
* had an allergic reaction to any of the drugs
* abusing alcohol or drugs
Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gadjah Mada University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sholahuddin Rhatomy

Head Of orthopaedic and Traumatology Department, Dr Soeradji Tirtonegoro Hospital/Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

sholahuddin rhatomy, dr

Role: PRINCIPAL_INVESTIGATOR

Gadjah Mada University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sholahuddin Rhatomy

Sleman, Special Region of Yogyakarta, Indonesia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Indonesia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

sholahuddin rhatomy, Dr

Role: CONTACT

+6281808720707

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

sholahuddin rhatomy, Dr

Role: primary

+6281808720707

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ACB OUTPATIENT CLINIC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Periarticular Injection Versus Popliteal Block
NCT04575688 ENROLLING_BY_INVITATION PHASE4